Summarize Paper logo SummarizePaper.com

Search Results for « EGFR »

Search by
Refine results

Years refer to the arXiv submission date or the publication date. Journal and ORCID filters use indexed publication records.

    Include journals

    Match any selected journal.

    Exclude journals

    Exclude every selected journal.

    Clear filters
    Log in to save this search or create a watch Saved searches

    Some sources are temporarily unavailable. Results may be incomplete; please try again shortly.

    YAP/TAZ-mediated resistance to EGFR inhibitors
    Hirohito Yamaguchi, Ghina M. Taouk
    Overcoming Resistance to EGFR Inhibitors in EGFR-Mutant NSCLC 2023-01-01 Summary from the abstract
    EGFR Mutations, Other Molecular Alterations Related To Sensitivity to EGFR Inhibitors, and Molecular Testing for EGFR-Targeted Therapies in Non-Small Cell Lung Cancer
    David A. Eberhard
    EGFR Signaling Networks in Cancer Therapy 2008-01-01 Summary from the abstract
    Copyright
    Overcoming Resistance to EGFR Inhibitors in EGFR-Mutant NSCLC 2023-01-01 Summary from the abstract
    Apoptosis signaling in EGFR inhibitor resistance in NSCLC
    Yeliz Aka, Bahriye Karakas, Ozgur Kutuk
    Overcoming Resistance to EGFR Inhibitors in EGFR-Mutant NSCLC 2023-01-01 Summary from the abstract
    The development and implementation of EGFR inhibitors in advanced NSCLC
    Alex Neuwelt, D. Ross Camidge
    Overcoming Resistance to EGFR Inhibitors in EGFR-Mutant NSCLC 2023-01-01 Summary from the abstract
    Historical development of EGFR-targeted therapy
    Sebastiao N. Martins-Filho, Ming-Sound Tsao
    Overcoming Resistance to EGFR Inhibitors in EGFR-Mutant NSCLC 2023-01-01 Summary from the abstract
    Index
    Overcoming Resistance to EGFR Inhibitors in EGFR-Mutant NSCLC 2023-01-01 Summary from the abstract
    Control of EGFR signaling by endocytosis and endosomal trafficking
    Chinmoy Ghosh, Yanli Xing, Yue Sun
    Overcoming Resistance to EGFR Inhibitors in EGFR-Mutant NSCLC 2023-01-01 Summary from the abstract
    Front Matter
    Overcoming Resistance to EGFR Inhibitors in EGFR-Mutant NSCLC 2023-01-01 Summary from the abstract
    Epithelial-mesenchymal transition and resistance to EGFR inhibitors
    Sheeba Jacob, Richard Kurupi, Anthony C. Faber
    Overcoming Resistance to EGFR Inhibitors in EGFR-Mutant NSCLC 2023-01-01 Summary from the abstract